Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page
- Check5 days agoChange DetectedThe recruitment status was updated to No longer looking for participants, new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was standardized with a revision note updated to v3.6.0.SummaryDifference0.3%

- Check12 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedVersion v3.5.4 replaces v3.5.3. This appears to be a routine site update rather than a modification to study content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision now lists v3.5.3 as the current revision, replacing the previous v3.5.2, indicating an update to the page's revision history.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.5.2 deployed, replacing v3.5.0. This update appears to be an internal version change with no visible changes to the study details page content.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.